Lacotide 150mg Tablet contains lacosamide, an antiepileptic agent indicated for the treatment of partial-onset seizures in patients with epilepsy. Lacosamide acts by selectively enhancing slow inactivation of voltage-gated sodium channels, stabilizing hyperexcitable neuronal membranes, and inhibiting repetitive neuronal firing. This mechanism contributes to its efficacy in reducing seizure frequency and severity. Lacotide is administered orally, with a recommended dosage individualized based on patient response and tolerability. It is typically initiated at a lower dose and gradually titrated to minimize adverse effects. Common side effects include dizziness, headache, nausea, and fatigue, though serious adverse reactions are rare. Caution is advised in patients with cardiac conduction abnormalities, as lacosamide may prolong PR interval. Regular monitoring of cardiac function is recommended in at-risk populations. Lacotide may interact with other antiepileptic drugs and medications that affect cardiac conduction; therefore, a thorough medication review is essential prior to initiation. It is contraindicated in patients with hypersensitivity to lacosamide or any tablet excipients. Lacotide 150mg Tablet offers an effective adjunctive treatment option for partial-onset seizures, improving seizure control and patient quality of life when used as part of a comprehensive epilepsy management plan under medical supervision.